Clinical Trial Update: Effect of SGLT2i on Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the effect of an SGLT2 inhibitor on diabetic retinopathy in patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Snippet

Sponsor: Nidae Alaa | Conditions: Diabetic Retinopathy | Phase 3 | Status: UNKNOWN